Salt tolerant membrane adsorbers for robust impurity clearance

Clearance of impurities such as viruses, host cell protein (HCP), and DNA is a critical purification design consideration for manufacture of monoclonal antibody therapeutics. Anion exchange chromatography has frequently been utilized to accomplish this goal; however, anion exchange adsorbents based on the traditional quaternary amine (Q) ligand are sensitive to salt concentration, leading to reduced clearance levels of impurities at moderate salt concentrations (50–150 mM). In this report, membrane adsorbers incorporating four alternative salt tolerant anion exchange ligands were examined for impurity clearance: agmatine, tris‐2‐aminoethyl amine, polyhexamethylene biguanide (PHMB), and polyethyleneimine. Each of these ligands provided greater than 5 log reduction value (LRV) for viral clearance of phage ϕX174 (pI ∼ 6.7) at pH 7.5 and phage PR772 (pI ∼ 4) at pH 4.2 in the presence of salt. Under these same conditions, the commercial Q membrane adsorber provided no clearance (zero LRV). Clearance of host‐cell protein at pH 7.5 was the most challenging test case; only PHMB maintained 1.5 LRV in 150 mM salt. The salt tolerance of PHMB was attributed to its large positive net charge through the presence of multiple biguanide groups that participated in electrostatic and hydrogen bonding interactions with the impurity molecules. On the basis of the results of this study, membrane adsorbers that incorporate salt tolerant anion exchange ligands provide a robust approach to impurity clearance during the purification of monoclonal antibodies. © 2009 American Institute of Chemical Engineers Biotechnol. Prog., 2009

[1]  Hazel Aranha,et al.  Characterization of Coliphage PR772 and Evaluation of Its Use for Virus Filter Performance Testing , 2004, Applied and Environmental Microbiology.

[2]  M. Etzel,et al.  Evaluation of an ion‐exchange membrane for the purification of plasmid DNA , 2003, Biotechnology and applied biochemistry.

[3]  S. Wickramasinghe,et al.  Binding Aedes aegypti densonucleosis virus to ion exchange membranes. , 2005, Journal of chromatography. A.

[4]  U. Reichl,et al.  Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers , 2007 .

[5]  C. Roth,et al.  Mechanistic model of retention in protein ion-exchange chromatography , 1996 .

[6]  Raja Ghosh,et al.  Protein separation using membrane chromatography: opportunities and challenges. , 2002, Journal of chromatography. A.

[7]  H. Brandwein,et al.  Application of bacteriophages as surrogates for mammalian viruses: a case for use in filter validation based on precedents and current practices in medical and environmental virology. , 1999, PDA journal of pharmaceutical science and technology.

[8]  C. Dowd,et al.  Performance of a membrane adsorber for trace impurity removal in biotechnology manufacturing. , 2005, Journal of chromatography. A.

[9]  Saiful,et al.  Enzyme capturing and concentration with mixed matrix membrane adsorbers , 2006 .

[10]  Steven Cramer,et al.  Evaluation of multi-modal high salt binding ion exchange materials. , 2007, Journal of Chromatography A.

[11]  A. Jungbauer,et al.  Thermodynamic stability and formation of aggregates of human immunoglobulin G characterised by differential scanning calorimetry and dynamic light scattering. , 2006, Journal of biochemical and biophysical methods.

[12]  D. Harding,et al.  Hydrophobic charge induction chromatography: salt independent protein adsorption and facile elution with aqueous buffers. , 1998, Journal of chromatography. A.

[13]  J. M. Coco-Martin,et al.  A review of therapeutic protein expression by mammalian cells , 2008 .

[14]  D. Harding,et al.  High-density ligand attachment to brominated allyl matrices and application to mixed mode chromatography of chymosin , 1997 .

[15]  Uwe Gottschalk,et al.  New Q membrane scale-down model for process-scale antibody purification. , 2006, Journal of chromatography. A.

[16]  Bo-Lennart Johansson,et al.  Preparation and characterization of prototypes for multi-modal separation media aimed for capture of negatively charged biomolecules at high salt conditions. , 2003, Journal of chromatography. A.

[17]  R L Fahrner,et al.  Membrane ion-exchange chromatography for process-scale antibody purification. , 2001, Journal of chromatography. A.

[18]  R. Freitag,et al.  High-performance membrane chromatography of supercoiled plasmid DNA. , 1998, Analytical chemistry.

[19]  Kurt Brorson,et al.  Generic/matrix evaluation of SV40 clearance by anion exchange chromatography in flow‐through mode , 2003, Biotechnology and bioengineering.

[20]  Quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. ICH Harmonised Tripartite Guideline. , 1998, Developments in biological standardization.

[21]  R. Guzman,et al.  Breakthrough Performance of Plasmid DNA on Ion‐Exchange Membrane Columns , 2007, Biotechnology progress.

[22]  S. Lute,et al.  Phage passage after extended processing in small‐virus‐retentive filters , 2007, Biotechnology and applied biochemistry.

[23]  Thomas Scheper,et al.  Fast and efficient protein purification using membrane adsorber systems. , 2006, Journal of biotechnology.

[24]  Joe X. Zhou,et al.  Viral clearance using disposable systems in monoclonal antibody commercial downstream processing , 2008, Biotechnology and bioengineering.

[25]  Ann L. Lee,et al.  Membrane chromatography of DNA: Conformation‐induced capacity and selectivity , 2004, Biotechnology and bioengineering.

[26]  Jörg Thömmes,et al.  Alternatives to Chromatographic Separations , 2007, Biotechnology progress.

[27]  Cristiana Boi,et al.  Membrane adsorbers as purification tools for monoclonal antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[28]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[29]  F. Švec,et al.  Monolithic materials : preparation, properties and applications , 2003 .

[30]  Hazel Aranha,et al.  Disposable processing gains you a competitive edge: Enhancing manufacturing capacity with disposable filters, connectors, and membrane chromatography , 2003 .

[31]  Mark R. Etzel,et al.  Purification of a large protein using ion-exchange membranes , 2002 .

[32]  J. Rothbard,et al.  Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. , 2005, Advanced drug delivery reviews.

[33]  T. Puck,et al.  GENETICS OF SOMATIC MAMMALIAN CELLS III. LONG-TERM CULTIVATION OF EUPLOID CELLS FROM HUMAN AND ANIMAL SUBJECTS , 1958 .

[34]  M. Etzel Chapter 10 – Layered Stacks , 2003 .

[35]  Kurt Brorson,et al.  Characterization and purification of bacteriophages using chromatofocusing. , 2008, Journal of chromatography. A.

[36]  M. Yavuz Corapcioglu,et al.  Delineating the Specific Influence of Virus Isoelectric Point and Size on Virus Adsorption and Transport through Sandy Soils , 1998, Applied and Environmental Microbiology.

[37]  B. L. Thomas,et al.  Adsorptive membrane chromatography for purification of plasmid DNA. , 2003, Journal of chromatography. A.

[38]  K. Brorson,et al.  Design of salt‐tolerant membrane adsorbers for viral clearance , 2009, Biotechnology and Bioengineering.

[39]  Suzanne S. Farid,et al.  Economic Drivers and Trade-Offs in Antibody Purification Processes : The future of therapeutic MAbs lies in the development of economically feasible downstream processes , 2008 .

[40]  U. Gottschalk Downstream processing of monoclonal antibodies : from high dilution to high purity , 2005 .

[41]  Joe X. Zhou,et al.  Basic Concepts in Q Membrane Chromatography for Large‐Scale Antibody Production , 2006, Biotechnology progress.